ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer

Xie, Yongwei; Chen, Yu; Wang, Qiucheng; Li, Bo; Shang, Haitao; Jing, Hui*哈尔滨医科大学
Ultrasound in Medicine and Biology2023-7DOI: 10.1016/j.ultrasmedbio.2023.03.017
1被引13阅读
引用收藏
分享

摘要

Objective: This prospective study was aimed at evaluating the role of automated breast ultrasound (ABUS) and contrast-enhanced ultrasound (CEUS) in the early prediction of treatment response to neoadjuvant chemotherapy (NAC) in patients with breast cancer.Methods: Forty-three patients with pathologically confirmed invasive breast cancer treated with NAC were included. The standard for evaluation of response to NAC was based on surgery within 21 d of completing treat-ment. The patients were classified as having a pathological complete response (pCR) and a non-pCR. All patients underwent CEUS and ABUS 1 wk before receiving NAC and after two treatment cycles. The rising time (RT), time to peak (TTP), peak intensity (PI), wash-in slope (WIS) and wash-in area under the curve (Wi-AUC) were mea-sured on the CEUS images before and after NAC. The maximum tumor diameters in the coronal and sagittal planes were measured on ABUS, and the tumor volume (V) was calculated. The difference (?) in each parameter between the two treatment time points was compared. Binary logistic regression analysis was used to identify the predic-tive value of each parameter.Results: ?V, ?TTP and ?PI were independent predictors of pCR. The CEUS-ABUS model achieved the highest AUC (0.950), followed by those based on CEUS (0.918) and ABUS (0.891) alone.Conclusion: The CEUS-ABUS model could be used clinically to optimize the treatment of patients with breast cancer.

学科与关键词

关键词
Contrast -enhanced ultrasoundAutomated breast ultrasoundBreast cancerNeoadjuvant chemotherapyPathological complete remission
相关
加载中…
  • Prediction of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer using a combination of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging
    Han, Xue; Yang, Huajing; Jin, Shiyang; Sun, Yunfeng; Zhang, Hongxia; Shan, Ming; Cheng, Wen*Cancer Medicine, 2023, 12(2): 1389-1398.被引 1
  • Radiomics Based on DCE-MRI for Predicting Response to Neoadjuvant Therapy in Breast Cancer
    Zeng, Qiao; Xiong, Fei; Liu, Lan; Zhong, Linhua; Cai, Fengqin; Zeng, Xianjun*ACADEMIC RADIOLOGY, 2023, 30 Suppl 2: S38-S49.
  • Value of shear wave elasticity in predicting the efficacy of neoadjuvant chemotherapy in different molecular types
    Yuan, Shasha; Shao, Hua; Na, Ziyue; Kong, Mengqiong*; Cheng, Wen*CLINICAL IMAGING, 2022, 89: 97-103.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Ultrasound in Medicine and Biology
发表日期
2023-07
卷期
第 49 卷, 第 7 期
页码
1638-1646
DOI
10.1016/j.ultrasmedbio.2023.03.017
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82171953]; HAI YAN Science Foundation of Harbin Medical University Cancer Hospital [JJMS2020-01]

作者

  • X

    Xie, Yongwei (第一作者)

    harbin med univ

  • C

    Chen, Yu

    harbin med univ

查看全部 6 位作者收起作者
  • W

    Wang, Qiucheng

    harbin med univ

  • L

    Li, Bo

    harbin med univ

  • S

    Shang, Haitao

    harbin med univ

  • J

    Jing, Hui (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417